Publicacións en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (13)

2023

  1. Quality indicators in the rational management of severe asthma: A Spanish multidisciplinary consensus

    Journal of Healthcare Quality Research, Vol. 38, Núm. 5, pp. 277-283

  2. Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response

    Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 1, pp. 1-13

  3. Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 842-845

  4. Validation of the Asthma Impairment and Risk Questionnaire in Spain: A Useful Tool for Assessing Asthma Control in Adolescents and Adults

    Journal of Investigational Allergology and Clinical Immunology

2022

  1. Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases

    Archivos de Bronconeumologia, Vol. 58, pp. 39-50

2020

  1. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057

  2. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042

  3. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068

2018

  1. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: A network approach

    International Journal of COPD, Vol. 13, pp. 591-601

2017

  1. Asthma-COPD overlap is not a homogeneous disorder: Further supporting data

    Respiratory Research

2016

  1. GEMA 4.0 Spanish guidelines of the management of Asthma

    Journal of Investigational Allergology and Clinical Immunology

  2. Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients

    Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152

2011

  1. Effects of omalizumab in Aspergillus-associated airway disease

    Thorax